Altered expression of fucosyltransferases in colorectal cancer
Project/Area Number |
17K10643
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Digestive surgery
|
Research Institution | Fukushima Medical University |
Principal Investigator |
Noda Masaru 福島県立医科大学, 医学部, 助教 (50769643)
|
Co-Investigator(Kenkyū-buntansha) |
岡山 洋和 福島県立医科大学, 医学部, 講師 (20583397)
門馬 智之 福島県立医科大学, 医学部, 准教授 (20622335)
坂本 渉 福島県立医科大学, 医学部, 講師 (40622337)
|
Project Period (FY) |
2017-04-01 – 2022-03-31
|
Project Status |
Completed (Fiscal Year 2021)
|
Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2019: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2018: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2017: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
Keywords | 大腸癌 / フコース転移酵素 / 糖鎖 / p53 / 分子サブタイプ |
Outline of Final Research Achievements |
The present study focused on alpha1-6 fucosyltransferase, an enzyme responsible for core fucosylation encoded by FUT8. As the FUT8 gene has recently been identified as a direct transcriptional target of wild-type p53, we specifically investigated the expression of FUT8 in conjunction with p53 alterations in colorectal cancer. FUT8 mRNA levels were significantly decreased in tumors hrboring mutant TP53, compared to those of wild-type TP53. Using immunohistochemistry, positive expression of FUT8 protein was associated with survival only in tumors with negative p53, while it had no prognostic impact in tumors with positive p53. Although we also found that the expression of polypeptide N-acetylgalactosamine (GalNAc) transferase 6 was significantly decreased in BRAF mutant tumors compared to those of wild-type, the in vitro role of mutant BRAF in regulation of this enzyme remains inconclusive.
|
Academic Significance and Societal Importance of the Research Achievements |
大腸癌において、α1‐6 fucosyltransferase発現のゲノム異常との関連、臨床的意義を解明することは、大腸癌の発癌、進展における生物学的機構を理解する一助となり得るとともに、大腸癌治療の個別化にも寄与しうる可能性がある。
|
Report
(6 results)
Research Products
(14 results)
-
-
-
-
-
-
-
-
-
[Presentation] MSI/dMMR大腸癌のsubclassification2021
Author(s)
岡山洋和, 松本拓朗, 遠藤英成, 中嶋正太郎, 金田晃尚, 伊藤美郷, 菅家康之, 小野澤寿志, 藤田正太郎, 坂本渉, 齋藤元伸, 佐瀬善一郎, 門馬智之, 三村耕作, 河野浩二
Organizer
第59回日本癌治療学会学術集会
Related Report
-
[Presentation] 大腸癌におけるTn 抗原の発現2020
Author(s)
松本拓朗, 岡山洋和, 加瀬晃志, 仲野宏, 遠藤英成, 伊藤美郷, 山田玲央, 小野澤寿志, 藤田正太郎, 坂本渉, 齋藤元伸, 三村耕作, 佐瀬善一郎, 門馬智之, 河野浩二.
Organizer
第58回日本癌治療学会学術集会
Related Report
-
-
[Presentation] 脱フコシル化抗体を用いたADCCの検討2017
Author(s)
中島 隆宏,河野 浩二,芦澤 舞,千田 峻,野田 勝,青砥 慶太,立花 和之進,岡山 洋和,早瀬 傑,坂本 渉,石亀 輝英,齋藤 元伸,志村 龍男,大竹 徹,竹之下 誠一
Organizer
第117回日本外科学会定期学術集会
Related Report
-
-